Research Article
Cryoablation of Primary Breast Cancer in Patients with Metastatic Disease: Considerations Arising from a Single-Centre Data Analysis
Table 2
Data relative to the cryoablation procedures in the study population.
| | Number (%) |
| Total number of treatments performed | 48 (100) | Upfront cryoablation treatment | 35 (72.9) | Redo cryoablation for incomplete necrosis | 5 (10.4) | Redo cryoablation for local recurrence | 7 (14.6) | Cryoablation for new contralateral breast cancer | 1 (2.1) | Types of probe used for cryoablations | | IceRod | 48 (50.0) | IceRod Plus | 28 (29.2) | IceSphere | 20 (20.8) | Number of cryoprobes used per treatment | | 1 cryoprobe | 9 (18.7) | 2 cryoprobes | 30 (62.6) | 3 cryoprobes | 9 (18.7) | Synchronous cryoablation of metastases | | Axillary lymph node | 2 (4.2) | Sternal bone | 1 (2.1) | Two-month follow-up MRI/CT scan | | Complete tumor necrosis | 30 (85.7) | Incomplete tumor necrosis | 5 (14.2) | Six-month follow-up MRI/CT scan | | Complete tumor necrosis | 35 (100) | Incomplete tumor necrosis | 0 (0) | Complications | | Major complications | 0 (0) | Minor side effects | 30 (82%) |
|
|